231 related articles for article (PubMed ID: 27371685)
1. Selective serotonin reuptake inhibitor exposure constricts the mouse ductus arteriosus in utero.
Hooper CW; Delaney C; Streeter T; Yarboro MT; Poole S; Brown N; Slaughter JC; Cotton RB; Reese J; Shelton EL
Am J Physiol Heart Circ Physiol; 2016 Sep; 311(3):H572-81. PubMed ID: 27371685
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary vascular effects of serotonin and selective serotonin reuptake inhibitors in the late-gestation ovine fetus.
Delaney C; Gien J; Grover TR; Roe G; Abman SH
Am J Physiol Lung Cell Mol Physiol; 2011 Dec; 301(6):L937-44. PubMed ID: 21908589
[TBL] [Abstract][Full Text] [Related]
3. Role of dopamine and selective dopamine receptor agonists on mouse ductus arteriosus tone and responsiveness.
Crockett SL; Harris M; Boatwright N; Su RL; Yarboro MT; Berger CD; Shelton EL; Reese J; Segar JL
Pediatr Res; 2020 May; 87(6):991-997. PubMed ID: 31816622
[TBL] [Abstract][Full Text] [Related]
4. The effect of selective serotonin reuptake inhibitors (SSRIs) on the pharmacokinetics and metabolism of perazine in the rat.
Daniel WA; Syrek M; Haduch A; Wójcikowski J
J Pharm Pharmacol; 2001 Apr; 53(4):449-61. PubMed ID: 11341361
[TBL] [Abstract][Full Text] [Related]
5. Hypobaric hypoxia exposure in rats differentially alters antidepressant efficacy of the selective serotonin reuptake inhibitors fluoxetine, paroxetine, escitalopram and sertraline.
Kanekar S; Sheth CS; Ombach HJ; Olson PR; Bogdanova OV; Petersen M; Renshaw CE; Sung YH; D'Anci KE; Renshaw PF
Pharmacol Biochem Behav; 2018 Jul; 170():25-35. PubMed ID: 29738811
[TBL] [Abstract][Full Text] [Related]
6. Selective Serotonin Reuptake Inhibitors and Persistent Pulmonary Hypertension of the Newborn: An Update Meta-Analysis.
Ng QX; Venkatanarayanan N; Ho CYX; Sim WS; Lim DY; Yeo WS
J Womens Health (Larchmt); 2019 Mar; 28(3):331-338. PubMed ID: 30407100
[TBL] [Abstract][Full Text] [Related]
7. Serotonin contributes to high pulmonary vascular tone in a sheep model of persistent pulmonary hypertension of the newborn.
Delaney C; Gien J; Roe G; Isenberg N; Kailey J; Abman SH
Am J Physiol Lung Cell Mol Physiol; 2013 Jun; 304(12):L894-901. PubMed ID: 23605003
[TBL] [Abstract][Full Text] [Related]
8. In vivo identification and characterization of binding sites for selective serotonin reuptake inhibitors in mouse brain.
Hirano K; Maruyama S; Kimura R; Kagawa Y; Yamada S
Life Sci; 2004 Oct; 75(24):2933-45. PubMed ID: 15454344
[TBL] [Abstract][Full Text] [Related]
9. Role of prostaglandin E and its receptors in the process of ductus arteriosus maturation and functional closure in the rabbit.
Fan FL; Zhu S; Chen LH; Zou YL; Fan LH; Kang JH; Ma AQ; Guan YF
Clin Exp Pharmacol Physiol; 2010 May; 37(5-6):574-80. PubMed ID: 20082631
[TBL] [Abstract][Full Text] [Related]
10. Regulation of the fetal mouse ductus arteriosus is dependent on interaction of nitric oxide and COX enzymes in the ductal wall.
Reese J; O'Mara PW; Poole SD; Brown N; Tolentino C; Eckman DM; Aschner JL
Prostaglandins Other Lipid Mediat; 2009 Apr; 88(3-4):89-96. PubMed ID: 19049898
[TBL] [Abstract][Full Text] [Related]
11. Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn.
Chambers CD; Hernandez-Diaz S; Van Marter LJ; Werler MM; Louik C; Jones KL; Mitchell AA
N Engl J Med; 2006 Feb; 354(6):579-87. PubMed ID: 16467545
[TBL] [Abstract][Full Text] [Related]
12. Dual, constrictor-to-dilator, response of the mouse ductus arteriosus to the microsomal prostaglandin E synthase-1 inhibitor, 2-(6-chloro-1H-phenanthro[9,10d]imidazole- 2-yl)isophthalonitrile.
Baragatti B; Scebba F; Sodini D; Pagni E; Ciofini E; Xu D; Coceani F
Neonatology; 2011; 100(2):139-46. PubMed ID: 21372596
[TBL] [Abstract][Full Text] [Related]
13. Persistent pulmonary hypertension of the newborn and selective serotonin reuptake inhibitors: lessons from clinical and translational studies.
Occhiogrosso M; Omran SS; Altemus M
Am J Psychiatry; 2012 Feb; 169(2):134-40. PubMed ID: 22420034
[TBL] [Abstract][Full Text] [Related]
14. Maternal fluoxetine treatment in the postpartum period: effects on platelet serotonin and plasma drug levels in breastfeeding mother-infant pairs.
Epperson CN; Jatlow PI; Czarkowski K; Anderson GM
Pediatrics; 2003 Nov; 112(5):e425. PubMed ID: 14595087
[TBL] [Abstract][Full Text] [Related]
15. Assessing SSRIs' effects on fetal cardiomyocytes utilizing placenta-fetus model.
Arumugasaamy N; Hurley-Novatny A; Lembong J; Kim PCW; Fisher JP
Acta Biomater; 2019 Nov; 99():258-268. PubMed ID: 31536839
[TBL] [Abstract][Full Text] [Related]
16. Model Placental Barrier Phenotypic Response to Fluoxetine and Sertraline: A Comparative Study.
Arumugasaamy N; Gudelsky A; Hurley-Novatny A; Kim PCW; Fisher JP
Adv Healthc Mater; 2019 Sep; 8(18):e1900476. PubMed ID: 31407872
[TBL] [Abstract][Full Text] [Related]
17. Fluoxetine during pregnancy: impact on fetal development.
Morrison JL; Riggs KW; Rurak DW
Reprod Fertil Dev; 2005; 17(6):641-50. PubMed ID: 16263070
[TBL] [Abstract][Full Text] [Related]
18. Third trimester fetal pulmonary artery Doppler blood flow velocity characteristics following prenatal selective serotonin reuptake inhibitor (SSRI) exposure.
Lim K; Sanders A; Brain U; Riggs W; Oberlander TF; Rurak D
Early Hum Dev; 2012 Aug; 88(8):609-15. PubMed ID: 22305713
[TBL] [Abstract][Full Text] [Related]
19. Relationship between brain serotonin transporter binding, plasma concentration and behavioural effect of selective serotonin reuptake inhibitors.
Hirano K; Kimura R; Sugimoto Y; Yamada J; Uchida S; Kato Y; Hashimoto H; Yamada S
Br J Pharmacol; 2005 Mar; 144(5):695-702. PubMed ID: 15678084
[TBL] [Abstract][Full Text] [Related]
20. Low-dose thromboxane A2 receptor stimulation promotes closure of the rat ductus arteriosus with minimal adverse effects.
Yokota T; Aida T; Ichikawa Y; Fujita T; Yokoyama U; Minamisawa S
Pediatr Res; 2012 Aug; 72(2):129-36. PubMed ID: 22717688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
